Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ditzel

Showing results (251-260 of 314) with videos related to

Pageof 32
Sort By:
The International Journal of Biochemistry & Cell Biology|November 22, 2021
SSX2 promotes the formation of a novel type of intranuclear lamin bodiesS Traynor, N D Jakobsen, M F Ebbesen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1995
Neutralizing recombinant human antibodies to a conformational V2- and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated by using an epitope-masking procedureH J Ditzel, J M Binley, J P Moore, et al.
Stem Cells (Dayton, Ohio)|June 11, 2017
Elucidation of Altered Pathways in Tumor-Initiating Cells of Triple-Negative Breast Cancer: A Useful Cell Model System for Drug ScreeningAnne G Christensen, Sidse Ehmsen, Mikkel G Terp, et al.
Acta Oncologica (Stockholm, Sweden)|December 5, 2012
Association of tissue inhibitor of metalloproteinases-1 and Ki67 in estrogen receptor positive breast cancerChristina Bjerre, Ann Knoop, Karsten Bjerre, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|August 16, 2014
Elucidation of epithelial-mesenchymal transition-related pathways in a triple-negative breast cancer cell line model by multi-omics interactome analysisJosch K Pauling, Anne G Christensen, Richa Batra, et al.
Oncotarget|August 17, 2016
Integrative analysis of miRNA and gene expression reveals regulatory networks in tamoxifen-resistant breast cancerTejal Joshi, Daniel Elias, Jan Stenvang, et al.
BMC Research Notes|October 21, 2011
Analytical variables influencing the performance of a miRNA based laboratory assay for prediction of relapse in stage I non-small cell lung cancer (NSCLC)Jesper Dahlgaard, Wiktor Mazin, Thomas Jensen, et al.
Expert Opinion on Therapeutic Targets|March 17, 2020
Overexpression of HMGA2 in breast cancer promotes cell proliferation, migration, invasion and stemnessBehzad Mansoori, Pascal H G Duijf, Ali Mohammadi, et al.
Cell Death & Disease|November 8, 2019
A functional genetic screen identifies the Mediator complex as essential for SSX2-induced senescenceNadine H Brückmann, Sofie N Bennedsen, Pascal H G Duijf, et al.
NPJ Precision Oncology|September 24, 2022
Co-targeting CDK2 and CDK4/6 overcomes resistance to aromatase and CDK4/6 inhibitors in ER+ breast cancerAbeer J Al-Qasem, Carla L Alves, Sidse Ehmsen, et al.
Pageof 32

Showing results (251-260 of 314) with videos related to

Sort By:
Pageof 32
The International Journal of Biochemistry & Cell Biology|November 22, 2021
SSX2 promotes the formation of a novel type of intranuclear lamin bodiesS Traynor, N D Jakobsen, M F Ebbesen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1995
Neutralizing recombinant human antibodies to a conformational V2- and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated by using an epitope-masking procedureH J Ditzel, J M Binley, J P Moore, et al.
Stem Cells (Dayton, Ohio)|June 11, 2017
Elucidation of Altered Pathways in Tumor-Initiating Cells of Triple-Negative Breast Cancer: A Useful Cell Model System for Drug ScreeningAnne G Christensen, Sidse Ehmsen, Mikkel G Terp, et al.
Acta Oncologica (Stockholm, Sweden)|December 5, 2012
Association of tissue inhibitor of metalloproteinases-1 and Ki67 in estrogen receptor positive breast cancerChristina Bjerre, Ann Knoop, Karsten Bjerre, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|August 16, 2014
Elucidation of epithelial-mesenchymal transition-related pathways in a triple-negative breast cancer cell line model by multi-omics interactome analysisJosch K Pauling, Anne G Christensen, Richa Batra, et al.
Oncotarget|August 17, 2016
Integrative analysis of miRNA and gene expression reveals regulatory networks in tamoxifen-resistant breast cancerTejal Joshi, Daniel Elias, Jan Stenvang, et al.
BMC Research Notes|October 21, 2011
Analytical variables influencing the performance of a miRNA based laboratory assay for prediction of relapse in stage I non-small cell lung cancer (NSCLC)Jesper Dahlgaard, Wiktor Mazin, Thomas Jensen, et al.
Expert Opinion on Therapeutic Targets|March 17, 2020
Overexpression of HMGA2 in breast cancer promotes cell proliferation, migration, invasion and stemnessBehzad Mansoori, Pascal H G Duijf, Ali Mohammadi, et al.
Cell Death & Disease|November 8, 2019
A functional genetic screen identifies the Mediator complex as essential for SSX2-induced senescenceNadine H Brückmann, Sofie N Bennedsen, Pascal H G Duijf, et al.
NPJ Precision Oncology|September 24, 2022
Co-targeting CDK2 and CDK4/6 overcomes resistance to aromatase and CDK4/6 inhibitors in ER+ breast cancerAbeer J Al-Qasem, Carla L Alves, Sidse Ehmsen, et al.
Pageof 32